SCYNEXIS Inc (SCYX)
1.47
-0.03
(-2.00%)
USD |
NASDAQ |
Apr 25, 16:00
1.45
-0.02
(-1.36%)
After-Hours: 20:00
SCYNEXIS Price: 1.47 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 1.48 | 1.490 | 1.42 | 1.47 | 120233.0 |
Apr 24, 2024 | 1.58 | 1.594 | 1.48 | 1.50 | 87668.00 |
Apr 23, 2024 | 1.48 | 1.606 | 1.48 | 1.55 | 153695.0 |
Apr 22, 2024 | 1.45 | 1.48 | 1.44 | 1.44 | 72655.00 |
Apr 19, 2024 | 1.41 | 1.470 | 1.39 | 1.44 | 130980.0 |
Apr 18, 2024 | 1.43 | 1.477 | 1.39 | 1.405 | 79920.00 |
Apr 17, 2024 | 1.40 | 1.46 | 1.37 | 1.42 | 127425.0 |
Apr 16, 2024 | 1.47 | 1.50 | 1.40 | 1.41 | 106303.0 |
Apr 15, 2024 | 1.49 | 1.52 | 1.43 | 1.47 | 128518.0 |
Apr 12, 2024 | 1.61 | 1.63 | 1.44 | 1.445 | 496787.0 |
Apr 11, 2024 | 1.61 | 1.61 | 1.55 | 1.60 | 144836.0 |
Apr 10, 2024 | 1.60 | 1.63 | 1.56 | 1.58 | 144685.0 |
Apr 09, 2024 | 1.66 | 1.67 | 1.58 | 1.63 | 156160.0 |
Apr 08, 2024 | 1.72 | 1.72 | 1.61 | 1.63 | 172242.0 |
Apr 05, 2024 | 1.69 | 1.79 | 1.670 | 1.71 | 125497.0 |
Apr 04, 2024 | 1.78 | 1.86 | 1.610 | 1.68 | 320762.0 |
Apr 03, 2024 | 1.55 | 1.85 | 1.54 | 1.80 | 724503.0 |
Apr 02, 2024 | 1.46 | 1.58 | 1.41 | 1.45 | 266616.0 |
Apr 01, 2024 | 1.52 | 1.525 | 1.42 | 1.49 | 284073.0 |
Mar 28, 2024 | 1.42 | 1.52 | 1.42 | 1.47 | 184086.0 |
Mar 27, 2024 | 1.41 | 1.46 | 1.40 | 1.425 | 107777.0 |
Mar 26, 2024 | 1.46 | 1.46 | 1.39 | 1.39 | 82857.00 |
Mar 25, 2024 | 1.39 | 1.46 | 1.39 | 1.43 | 146830.0 |
Mar 22, 2024 | 1.39 | 1.411 | 1.38 | 1.39 | 72439.00 |
Mar 21, 2024 | 1.43 | 1.47 | 1.37 | 1.40 | 150876.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.15
Minimum
Mar 17 2023
16.60
Maximum
Apr 26 2019
5.660
Average
5.33
Median
Sep 02 2020
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.077 |
Palatin Technologies Inc | 1.72 |
iBio Inc | 1.72 |
Theriva Biologics Inc | 0.4100 |
Oragenics Inc | 1.06 |
Price Related Metrics
PE Ratio | 1.131 |
PS Ratio | 0.5074 |
Price to Book Value | 0.7606 |
Price to Free Cash Flow | 1.182 |
Earnings Yield | 88.44% |
Market Cap | 55.50M |
Operating PE Ratio | 0.9785 |
Normalized PE Ratio | 1.057 |